The role of interferon alpha in initiation of type I diabetes in the NOD mouse

Clinical Immunology

Volumn 140, Issue 1, 2011, Pages 3-7

  Li, Qing ^a   Mcdevitt, Hugh O ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

IFN ; Plasmacytoid DC; Type 1 diabetes

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; ALPHA INTERFERON RECEPTOR MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INTERFERON PRODUCTION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PATHOGENESIS; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL;

ANIMALS; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; INTERFERON-ALPHA; MICE; MICE, INBRED NOD;

EID: 79958769172     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.04.010     Document Type: Article

References (25)

1. Anderson M.S., Bluestone J.A. The NOD mouse. Annu. Rev. Immunol. 2005, 23:447-485.
2. Theofilopoulos A.N., Baccala R., Beutler B., Kono D.H. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 2005, 23:307-336.
3. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
4. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999, 284:1835-1837.
5. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 2006, 6:823-835.
6. Li Q., Xu B., Michie S.A., Rubins K.H., Schreriber R.D., McDevitt H.O. Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:12439-12444.
7. Devendra D., Eisenbarth G.S. Interferon alpha-a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin. Immunol. 2004, 111:225-233.
8. Bach J.F. A Toll-like trigger for autoimmune disease. Nat. Med. 2005, 11:120-121.
9. Baxter A.G., Koulmanda M., Mandel T.E. High and low diabetes incidence nonobese diabetic (NOD) mice: origins and characterisation. Autoimmunity 1991, 9:61-67.
10. Krug A., French A.R., Barchet W., Fischer J.A., Dzionek A., Pingel J.T., Orihuela M.M., Akira S., Yokoyama W.M., Colonna M. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004, 21:107-119.
11. Bailey-Bucktrout S.L., Caulkins S.C., Goings G., Fischer J.A., Dzionek A., Miller S.D. Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J. Immunol. 2008, 180:6457-6461.
12. Isaksson M., Ardesjo B., Ronnblom L., Kampe O., Lassmann H., Eloranta M.L., Lobell A. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE. Eur. J. Immunol. 2009, 39:2925-2935.
13. Mathis D., Vence L., Benoist C. beta-Cell death during progression to diabetes. Nature 2001, 414:792-798.
14. Turley S., Poirot L., Hattori M., Benoist C., Mathis D. Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J. Exp. Med. 2003, 198:1527-1537.
15. Kim H.S., Han M.S., Chung K.W., Kim S., Kim E., Kim M.J., Jang E., Lee H.A., Youn J., Akira S., Lee M.S. Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. Immunity 2007, 27:321-333.
16. Lee A.S., Ghoreishi M., Cheng W.K., Zhang T.Y., Dutz J.P. Toll-like receptor 7 stimulation promotes autoimmune diabetes in the NOD mouse. Diabetologia 2011 Feb 22, Epub ahead of print.
17. Zhang Y., Lee A.S., Shameli A., Geng X., Finegood D., Santamaria P., Dutz J.P. TLR9 blockade inhibits activation of Diabetogenic CD8+ T cells and delays autoimmune diabetes. J. Immunol. 2010, 184:5645-5653.
18. Ginsberg-Fellner F., Witt M.E., Yagihashi S., Dobersen M.J., Taub F., Fedun B., McEvoy R.C., Roman S.H., Davies R.G., Cooper L.Z. The nature of the principal type 1 interferon-producing cells in human blood. Diabetologia 1984, 27:87-89. Suppl.
19. Devendra D., Liu E., Eisenbarth G. Type 1 diabetes: recent developments. BMJ 2004, 328:750-754.
20. Hyoty H., Hiltunen M., Knip M., Laakkonen M., Vahasalo P., Karjalainen J., Koskela P., Roivainen M., Leinikki P., Hovi T. High frequency of diabetes mellitus in young adults with congenital rubella. Diabetes 1995, 44:652-657.
21. Dotta F., Censini S., van Halteren A.G., Marselli L., Masini M., Dionisi S., Mosca F., Boggi U., Muda A.O., Prato S.D., Elliott J.F., Covacci A., Rappuoli R., Roep B.O., Marchetti P. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:5115-5120.
22. Londono P., Komura A., Hara N., Zipris D. Brief dexamethasone treatment during acute infection prevents virus-induced autoimmune diabetes. Clin. Immunol. 2010, 135:401-411.
23. Filippi C.M., von Herrath M.G. Viral antibodies in diabetes mellitus, viral trigger for type 1 diabetes: pros and cons. Diabetes 2008, 57:2863-2871.
24. Stewart T.A., Hultgren B., Huang X., Pitts-Meek S., Hully J., MacLachlan N.J. Induction of type I diabetes by interferon-alpha in transgenic mice. Science 1993, 260:1942-1946.
25. Fabris P., Betterle C., Floreani A., Greggio N.A., de Lazzari F., Naccarato R., Chiaramonte M. Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet 1992, 340:548.